These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8427117)

  • 1. Increased production of thromboxane A2 by coronary arteries after thrombolysis.
    Saldeen TG; Saldeen P; Nichols WW; Lawson DL; Nicolini FA; Mehta JL
    Am Heart J; 1993 Feb; 125(2 Pt 1):277-84. PubMed ID: 8427117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous prostaglandin endoperoxides and prostacyclin modulate the thrombolytic activity of tissue plasminogen activator. Effects of simultaneous inhibition of thromboxane A2 synthase and blockade of thromboxane A2/prostaglandin H2 receptors in a canine model of coronary thrombosis.
    Golino P; Rosolowsky M; Yao SK; McNatt J; De Clerck F; Buja LM; Willerson JT
    J Clin Invest; 1990 Oct; 86(4):1095-102. PubMed ID: 2145320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular prostaglandin and thromboxane production in a canine model of myocardial ischemia.
    Schmitz JM; Apprill PG; Buja LM; Willerson JT; Campbell WB
    Circ Res; 1985 Aug; 57(2):223-31. PubMed ID: 3926340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological basis of failure of concurrent glyceryl trinitrate therapy to improve efficacy of tissue type plasminogen activator in coronary thrombosis.
    Nicolini FA; Nichols WW; Saldeen TG; Mehta JL
    Cardiovasc Res; 1991 Apr; 25(4):283-9. PubMed ID: 1909212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased thromboxane biosynthesis during coronary thrombolysis. Evidence that platelet activation and thromboxane A2 modulate the response to tissue-type plasminogen activator in vivo.
    Fitzgerald DJ; Wright F; FitzGerald GA
    Circ Res; 1989 Jul; 65(1):83-94. PubMed ID: 2500270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mediation of reocclusion by thromboxane A2 and serotonin after thrombolysis with tissue-type plasminogen activator in a canine preparation of coronary thrombosis.
    Golino P; Ashton JH; Glas-Greenwalt P; McNatt J; Buja LM; Willerson JT
    Circulation; 1988 Mar; 77(3):678-84. PubMed ID: 3124975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of prostacyclin analog iloprost to sustain coronary blood flow after recombinant tissue-type plasminogen-induced thrombolysis in dogs.
    Nichols WW; Nicolini FA; Khan S; Saldeen TG; Mehta JL
    Am Heart J; 1993 Aug; 126(2):285-92. PubMed ID: 7687816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of cyclic flow variations in stenosed canine coronary arteries by thromboxane A2/prostaglandin H2 receptor antagonists.
    Ashton JH; Schmitz JM; Campbell WB; Ogletree ML; Raheja S; Taylor AL; Fitzgerald C; Buja LM; Willerson JT
    Circ Res; 1986 Nov; 59(5):568-78. PubMed ID: 3542279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of prostacyclin synthesis as a possible cause of transient flow reduction in a partially constricted canine coronary artery.
    Tada M; Esumi K; Yamagishi M; Kuzuya T; Matsuda H; Abe H; Uchida Y; Murao S
    J Mol Cell Cardiol; 1984 Dec; 16(12):1137-49. PubMed ID: 6398370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous administration of thromboxane A2- and serotonin S2-receptor antagonists markedly enhances thrombolysis and prevents or delays reocclusion after tissue-type plasminogen activator in a canine model of coronary thrombosis.
    Golino P; Ashton JH; McNatt J; Glas-Greenwalt P; Yao SK; O'Brien RA; Buja LM; Willerson JT
    Circulation; 1989 Apr; 79(4):911-9. PubMed ID: 2494005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of inhibition of thrombin and blockade of thromboxane A2 synthetase and receptors enhances thrombolysis and delays reocclusion in canine coronary arteries.
    Yao SK; Ober JC; Ferguson JJ; Anderson HV; Maraganore J; Buja LM; Willerson JT
    Circulation; 1992 Dec; 86(6):1993-9. PubMed ID: 1451271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased prostacyclin and thromboxane A2 biosynthesis in atherosclerosis.
    Mehta JL; Lawson D; Mehta P; Saldeen T
    Proc Natl Acad Sci U S A; 1988 Jun; 85(12):4511-5. PubMed ID: 3132716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxygen radical scavenging agents as adjuvant therapy with tissue plasminogen activator in a canine model of coronary thrombolysis.
    Przyklenk K; Kloner RA
    Cardiovasc Res; 1993 Jun; 27(6):925-34. PubMed ID: 8221780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial neutrophil infiltration, lipid peroxidation, and antioxidant activity after coronary artery thrombosis and thrombolysis.
    Chen LY; Nichols WW; Hendricks J; Mehta JL
    Am Heart J; 1995 Feb; 129(2):211-8. PubMed ID: 7832091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary fish oil accelerates the response to coronary thrombolysis with tissue-type plasminogen activator. Evidence for a modest platelet inhibitory effect in vivo.
    Braden GA; Knapp HR; Fitzgerald DJ; FitzGerald GA
    Circulation; 1990 Jul; 82(1):178-87. PubMed ID: 2114234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of thromboxane A2 synthase inhibition, singly or combined with thromboxane A2/prostaglandin endoperoxide receptor antagonism, on occlusive thrombosis elicited by endothelial cell injury or by deep vascular damage in canine coronary arteries.
    Vandeplassche G; Hemans C; Van de Water A; Xhonneux R; Wouters L; Van Ammel K; De Clerck F
    Circ Res; 1991 Aug; 69(2):313-24. PubMed ID: 1830517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
    Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L
    J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of aspirin on local prostaglandin production and serotonin accumulation in a canine model with coronary cyclic flow variations or thrombosis.
    Yao SK; Benedict CR; Rosolowsky M; McNatt J; Falinska B; Campbell WB; Buja LM; Willerson JT
    J Mol Cell Cardiol; 1991 Apr; 23(4):473-82. PubMed ID: 1942081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proadifen-induced production of prostacyclin by equine peritoneal macrophages.
    Morris DD; Moore JN; Wiltshire N; Fischer K
    Am J Vet Res; 1989 May; 50(5):747-50. PubMed ID: 2499232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of selective endoperoxide/thromboxane A2 receptor antagonism with sulotroban on lysis time and reocclusion rate after tissue plasminogen activator-induced coronary thrombolysis in the dog.
    Shebuski RJ; Smith JM; Storer BL; Granett JR; Bugelski PJ
    J Pharmacol Exp Ther; 1988 Aug; 246(2):790-6. PubMed ID: 3136245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.